The licensing authority in Uttarakhand has taken action by suspending the licenses of 14 Patanjali products manufactured by Patanjali’s Divya Pharmacy. This decision comes as a result of a case involving misleading advertisements.

The banned products includes Drishti Eye drop, Swasari Gold, Swasari Vati, Bronchom, Swasari Pravahi, Swasari Avaleh and Mukta Vati Extra Power.

It also includes Lipidom, Bp Grit, Madhugrit, Madhunashini Vati Extra Power, Livamrit Advance, Livogrit and Eyegrit Gold.

Supreme Court Hearing

The Supreme Court is scheduled to hear the case regarding the apology by Yoga guru Ramdev and his associate Acharya Balkrishna on April 30.

Both individuals will be present in court on Tuesday. During the previous hearing on April 23, the Supreme Court expressed dissatisfaction with Patanjali for not prominently displaying their apology in newspapers.

The court questioned the size of the apology, comparing it to full-page advertisements for Patanjali products.

Patanjali responded and stated that they had published an apology in 67 newspapers. They are emphasizing their respect for the court and their commitment to avoiding future mistakes.

Expanded Apology and Previous Actions on Patanjali

Following the court’s order, Patanjali published a larger apology in newspapers. Prior to this, Ramdev and Balkrishna had tendered an “unconditional and unqualified apology” before the top court.

The apology was regarding advertisements that made exaggerated claims about the effectiveness of Patanjali products like Coronil during the pandemic.

Court’s Directives and IMA’s Plea

In November 2023, the Supreme Court directed Patanjali to halt advertisements for products claiming to treat ailments and disorders which are listed in the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.

This directive came in response to a plea filed by the Indian Medical Association (IMA). IMA sought action against Ramdev for criticizing modern medicine.

With the suspension of licenses for 14 Patanjali products, the Supreme Court continues to address the case of the published apology by Ramdev and Balkrishna.

This situation highlights the importance of responsible advertising and the need for companies to adhere to legal guidelines.

The outcome of the court hearing will determine the next steps in addressing the issue of misleading advertisements and their impact on consumers.